Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Roche
RocheRoche Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Roche match what happens in practice?
Public evidence
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
SignalHunt:deployment:Lunit
Public evidence
Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics
SignalHunt:deployment:PathAI
Public evidence
Roche to Acquire Digital Pathology Firm PathAI for up to $1.05B
SignalHunt:deployment:PathAI
Public evidence
Roche Announces Definitive Agreement to Acquire PathAI for up to $1.05 Billion
SignalHunt:validation:PathAI
Public evidence
Roche announces definitive agreement to acquire PathAI
SignalHunt:validation:PathAI
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 12 public external signal(s) across 6 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Roche through company records and external market activity.
- Category
- uncategorized
What HealthAratus is still learning
HealthAratus is beginning to understand Roche. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Roche is a healthcare technology company. It develops artificial intelligence tools designed to assist in clinical analysis.According to Roche
What Roche states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The tool provides signals to assist in clinical data analysis.
According to Roche
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
Reported publicly
How widely is this actually used?
Reported deployment
Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics
Reported publicly
How widely is this actually used?
Reported deployment
Roche to Acquire Digital Pathology Firm PathAI for up to $1.05B
Reported publicly
How widely is this actually used?
Reported deployment
Roche Announces Definitive Agreement to Acquire PathAI for up to $1.05 Billion
Reported publicly
How widely is this actually used?
Reported deployment
Roche announces definitive agreement to acquire PathAI
Reported publicly
How widely is this actually used?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Roche — healthcare AI tool referenced in 1 signal(s).
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Parent Company
Rochevendor
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Roche accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence
Related technologies